†Faculty of Biosciences, Pharmacy and Psychology, Institute of Biochemistry, Universität Leipzig, Brüderstrasse 34, 04103 Leipzig, Germany.
‡Integrated Research and Treatment Center Adiposity Diseases (IFB), Core Unit "Animal Models", Universität Leipzig, Liebigstrasse 21, 04103 Leipzig, Germany.
J Med Chem. 2015 May 28;58(10):4180-93. doi: 10.1021/jm501702q. Epub 2015 May 7.
Ghrelin and Y2 receptors play a central role in appetite regulation inducing opposite effects. The Y2 receptor induces satiety, while the ghrelin receptor promotes hunger and weight gain. However, the food regulating system is tightly controlled by interconnected pathways where redundancies can lead to poor efficacy and drug tolerance when addressing a single molecule. We developed a multitarget strategy to synthesize dual peptides simultaneously inhibiting the ghrelin receptor and stimulating the Y2 receptor. Dual peptides showed dual activity in vitro, and one compound induced a slight diminution of food intake in a rodent model of obesity. In addition, stability studies in rats revealed different behaviors between the dual peptide and its corresponding monomers. The Y2 receptor agonist was unstable in blood, while the dual peptide showed an intermediate stability compared to that of the highly stable ghrelin receptor inverse agonist.
胃饥饿素和 Y2 受体在食欲调节中发挥核心作用,产生相反的效果。Y2 受体诱导饱腹感,而胃饥饿素受体则促进饥饿感和体重增加。然而,食物调节系统受到相互关联的途径的严格控制,当针对单个分子时,冗余可能导致疗效不佳和药物耐受性。我们开发了一种多靶点策略,同时合成双重肽,以抑制胃饥饿素受体并刺激 Y2 受体。双重肽在体外表现出双重活性,一种化合物在肥胖啮齿动物模型中引起食物摄入量略有减少。此外,在大鼠中的稳定性研究揭示了双重肽与其相应单体之间的不同行为。Y2 受体激动剂在血液中不稳定,而双重肽的稳定性介于高度稳定的胃饥饿素受体反向激动剂和 Y2 受体激动剂之间。